The Globe and Mail reports in its Wednesday, Nov. 27, edition that Canaccord Genuity analyst Carey MacRury has reaffirmed his "buy" recommendation for Barrick Gold. The Globe's David Leeder writes in the Eye On Equities column that Mr. MacRury gave his share target a $1.50 (Canadian) trim to $33.50 (Canadian). Analysts on average target the shares at $24.69 (U.S.). Mr. MacRury says in a note: "Barrick's longer-term strategy continues to prioritize exploration and organic growth to sustain its gold production while downplaying M&A. In our view, M&A is a tool in the toolbox that can be used well or poorly but given Barrick's size, we struggle to see the company sustaining its production over the long term via internal opportunities alone. Our 'buy' rating reflects Barrick's gold production looking to be at an inflection point, strong balance sheet and inexpensive valuation at 0.56 times NAV, versus the senior peer average of 0.62 times." The Globe reported on Sept. 11 that RBC Dominion Securities rated Barrick "outperform." The shares could then be had for $26.88 (Canadian).